The FDA Made a Mistake Approving This ALS Medication
New in the Opinion vertical: Andrew Feld delves into the FDA's controversial 2022 approval of the ALS drug Relyvrio.
Weekly Health Digest: Nursing Homes, ALS, and “Healthy” Food
New from the @EmoryCSHH News Team: tracking nursing home business' data, a new ALS drug enters the marketplace, and the FDA is changing what is “healthy.”